Crispr Therapeutics shares owned by Ing Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ing Investment Management
from 13F filings
Historical chart of Ing Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Ing Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.9M | 29k | 64.81 |
| 2025-06-30 | $1.8M | 36k | 48.64 |
| 2025-03-31 | $472k | 14k | 34.03 |
| 2024-12-31 | $341k | 8.7k | 39.36 |
| 2024-09-30 | $407k | 8.7k | 46.98 |
| 2024-06-30 | $889k | 17k | 54.01 |
| 2024-03-31 | $1.8M | 26k | 68.16 |
| 2023-12-31 | $1.6M | 26k | 62.60 |
| 2023-09-30 | $917k | 20k | 45.39 |
| 2023-06-30 | $688k | 12k | 56.14 |
| 2023-03-31 | $565k | 13k | 45.23 |
| 2022-12-31 | $900k | 22k | 40.65 |
| 2022-09-30 | $1.4M | 22k | 65.35 |
| 2019-12-31 | $231k | 3.8k | 60.90 |